This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This transformation will particularly benefit organizations that can effectively combine AI expertise with traditional pharmaceutical knowledge, creating new competitive advantages in drugdevelopment efficiency, cost management, and market responsiveness.
Interoperability and data analytics: Merging companies with expertise in connecting disparate healthcare systems and generating actionable insights can be valuable. Interoperability and data analytics: Merging companies with expertise in connecting disparate healthcare systems and generating actionable insights can be valuable.
The ultimate goal for trials is to enhance the quality and efficiency of the study, ensuring the successful delivery of life-saving therapeutics. As sponsors adopt new tools, they will increasingly seek strategies that enable a harmonized, interoperable ecosystem.
According to an excellent whitepaper describing a case study of Medrec , a platform utilizing blockchain technology, health information interoperability is facilitated with the use of blockchain. However, interestingly, interoperability of blockchain itself remains as much a Holy Grail as interoperability of digital healthcare data.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content